Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Adastra Hldgs
(OTCEM:XTXXF)
Intraday
$0.185
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.185
0
[0.00%]
At close: Apr 5
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Adastra Hldgs Stock (OTC:XTXXF)
Adastra Hldgs Stock (OTC: XTXXF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses
Nina Zdinjak
-
Apr 25, 2024, 9:48AM
Thursday, August 24, 2023
Cannabis Stock Gainers And Losers From August 24, 2023
Benzinga Insights
-
Aug 24, 2023, 5:30PM
Friday, August 18, 2023
Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2
Nina Zdinjak
-
Aug 18, 2023, 11:07AM
Wednesday, May 31, 2023
Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What's Behind The Figures?
Jelena Martinovic
-
May 31, 2023, 1:33PM
Tuesday, May 02, 2023
Adastra FY22 Revenue Grows 136%, Here Is What You Need To Know
Vuk Zdinjak
-
May 2, 2023, 9:10AM
Thursday, March 16, 2023
Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit
Vuk Zdinjak
-
Mar 16, 2023, 10:55AM
Monday, March 13, 2023
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Lara Goldstein
-
Mar 13, 2023, 5:13PM
Tuesday, March 07, 2023
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Lara Goldstein
-
Mar 7, 2023, 10:29AM
Monday, March 06, 2023
Adastra Clarifies Health Canada Approval To Handle Cocaine
Vuk Zdinjak
-
Mar 6, 2023, 8:18AM
Friday, March 03, 2023
Canadian Weed Company's Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment
Jelena Martinovic
-
Mar 3, 2023, 11:15AM
Thursday, February 23, 2023
Canada Gives This Cannabis Company The Green Light To Handle Cocaine, Psilocybin
Jelena Martinovic
-
Feb 23, 2023, 4:43PM
Tuesday, December 06, 2022
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein
-
Dec 6, 2022, 2:20PM
Friday, December 02, 2022
Adastra Q3 Revenue Grows 110% YoY To $2.83M
Vuk Zdinjak
-
Dec 2, 2022, 7:54AM
Wednesday, August 31, 2022
Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin
Vuk Zdinjak
-
Aug 31, 2022, 10:00AM
Friday, May 20, 2022
Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies
Jelena Martinovic
-
May 20, 2022, 2:37PM
Monday, May 16, 2022
Adastra Holdings Appoints Smoke Wallin As New Director
Vuk Zdinjak
-
May 16, 2022, 11:59AM
Wednesday, May 04, 2022
Adastra Holdings Reports Record Revenue In 2021, Here Are The Details
Vuk Zdinjak
-
May 4, 2022, 11:24AM
Monday, April 11, 2022
Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services
Vuk Zdinjak
-
Apr 11, 2022, 10:35AM
Friday, March 25, 2022
Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD
Vuk Zdinjak
-
Mar 25, 2022, 12:02PM
